Raleigh, NC, Aug. 13, 2008 – INC Research ®, Inc., a therapeutically-focused contract research organization (CRO) with a process for delivering reliable results, today announced the appointment of Warren A. Prosser, MBA, CCRA as the vice president, Clinical Operations for Global Neurology. Prosser will lead INC Research’s neurology teams on Phase I-III trials, and provide strategic and developmental consultation to pharmaceutical customers within its central nervous system (CNS) division.
Prosser has 18 years experience designing, implementing, monitoring, and managing clinical trials in a variety of therapeutic areas including neurology, cardiovascular and metabolic diseases. His knowledge in CRO, pharmaceutical and academic settings gives him a broad perspective in conducting successful Phase I-III clinical trials on a global basis.
“Warren is a critical addition to our CNS team as we continue to grow strategically,” said Michael Gibertini, executive vice president CNS, INC Research. “He brings tremendous talent and breadth of experience across many areas of drug development, and has built a fine reputation in the industry. This appointment underscores our commitment to exceeding customer expectations with outsourced clinical trials services delivered through our Trusted Process.”
Most recently, Prosser held the senior director, Clinical Operations position at Arena Pharmaceuticals where he provided oversight for all clinical trials conducted within 5 clinical development programs. During his tenure, he co-authored and presented numerous posters and papers based on his work with obesity and sleep disorders, as well as industry issues such as dose selection, design of Phase III trials and advanced technology to enhance data quality. Prosser also held senior and associate management positions at Dura Pharmaceuticals, PPD Pharmaco and Duke University Medical Center.
“My experience has allowed me to view the drug development process from multiple perspectives, which has been invaluable,” said Prosser. “INC Research gives me the opportunity to apply my knowledge and therapeutic foresight to the clinical trials process.”
INC Research is a recognized leader in the field of CNS conducting hundreds of global trials focused on pain, neurology and psychiatry over the past 20 years. Trials have involved more than 70,000 patients at more than 6,600 sites worldwide.
About INC Research® Inc. INC Research is a therapeutically-focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women’s health trials. The company’s The Trusted Process® methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina, with 25 office locations and a presence in 32 countries worldwide. For more information please visit www.incresearch.com.
